RedHill Biopharma inks $1.8 million Middle East licensing deal for Talicia

RedHill will receive $500,000 in guaranteed payments, including a $250,000 upfront payment and $250,000 in fixed payments due within 18 months

Cipla appoints Prabhakaran Balakrishnan Nair as Global Chief Manufacturing Officer

RedHill Biopharma to submit FDA-approved Talicia for UK marketing authorisation

Talicia is also approved and launched in the UAE and additional countries may accept UK MHRA approvals as a reference for their own marketing approval processes

Informa Markets in India set to host 17th edition of CPHI & PMEC India Expo

CPHI & PMEC India Expo 2024 to bring over 50,000 industry professionals and 2,000 exhibitors under one roof

CPhI and P-MEC India sees participation of over 1500 exhibitors

40,000 visitors and representatives of more than 80 countries set to visit the show

Agilent Laboratory achieves Green Lab certification

This is the first Agilent lab to receive the My Green Lab Certification and plans are under way to certify additional labs.

Indian Pharma Market witnesses rise in volumes and prices in September.

Acute therapies continue to report strong growth compared to chronic ones.